Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function

B. Jenkins(Swansea University), Nicholas Jones(Swansea University), Gareth W. Jones(University of Bristol), David Sumpton(Cancer Research UK), Ursula Fearon(Trinity College Dublin), Joanne Davies(Swansea University), James A. Nathan(University of Cambridge), Fernando M. Ponce-Garcia(Swansea University), Douglas J. Veale(St. Vincent's University Hospital), J. Cronin(Swansea University), Ian R. Humphreys(Cardiff University), Ardena Berisha(National University of Ireland, Maynooth), Johan Vande Voorde(Cancer Research UK Scotland Institute), David K. Finlay(Trinity College), Federico Bernuzzi(Cancer Research UK), Julianna Blagih(Université de Montréal), Iain Perry(Swansea University), Benjamin F. Cravatt(Scripps Institution of Oceanography), Simon Eastham(University of Bristol), Morgan Marsden(Institute of Infection and Immunity), Marta Williams(Institute of Infection and Immunity), Andrew E. Hogan(National University of Ireland, Maynooth), Alexandra Howell(Institute of Infection and Immunity), Luke C. Davies(Swansea University), Yasmin R Jenkins(Swansea University), Chloe Moscrop(University of Bristol), Gonçalo Vale(The University of Texas Southwestern Medical Center), Emma E. Vincent(University of Bristol), Linda V. Sinclair(University of Dundee), Alejandro Huerta Uribe(University of Glasgow), James A. Pearson(Institute of Infection and Immunity), Micah J. Niphakis(San Diego Biomedical Research Institute), Matthew D. Hitchings(Swansea University), Jeffrey G. McDonald(The University of Texas Southwestern Medical Center)
Nature Communications
November 3, 2025
Cited by 0


Related Papers